
    
      45 patients are recruited in the study. Each study group will consist of 15 women (aged 20-35
      years) receiving oral, transdermal or transvaginal hormonal contraception continuously for 9
      weeks. The subjects should have at least 2 months wash out period from all hormonal
      medication prior to the study.

      The measurements for serum sampling and OGTT will be performed before and after 9 weeks of
      medication.
    
  